First human tests: new asthma drug shows promise in early safety trial
NCT ID NCT05366764
Summary
This early-stage study tested the safety and how the body processes a new asthma medication called SAR443765. The trial involved 36 participants, including healthy adults and people with mild-to-moderate asthma, who received either the drug or a placebo. Researchers monitored side effects and measured drug levels in the blood to understand how the medication behaves in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 2760001
Berlin, Germany
-
Investigational Site Number : 8260001
Belfast, BT9 6AD, United Kingdom
Conditions
Explore the condition pages connected to this study.